Search - tctmd.com

Displaying 161 - 180 of 302

Sort: Relevancy | Date

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

Caitlin E. Cox

September 30, 2021

News Daily News

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

Michael O'Riordan

September 27, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Daily News

Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering

Todd Neale

September 08, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Daily News

Apixaban May Be Best DOAC for Frail, Older Patients With AF

Todd Neale

July 19, 2021

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

Advertisement

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Vasopressor/Steroid Combo Jump-starts Circulation for In-Hospital Cardiac Arrests

High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Apixaban May Be Best DOAC for Frail, Older Patients With AF

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

OMT Boosts Survival in Revascularized Patients at 10 Years

Less Cancer Among HF Patients Taking Statins, Registry Shows

Elective Revascularization, Better Long-term Survival: Meta-analysis

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

May 2021 News Roundup

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Experts Fear Coronary CT Advice for Patients Misses the Mark

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content